Version
A CXCR4 Partial Agonist Improves Immunotherapy by Targeting Immunosuppressive Neutrophils and Cancer-Driven Granulopoiesis
CTSA https://pubmed.ncbi.nlm.nih.gov/40578360/ 2025-08-11T00:00:00Z Cancer Cell
CTSA https://pubmed.ncbi.nlm.nih.gov/40578360/ 2025-08-11T00:00:00Z Cancer Cell